KEI comments on Tibotec voluntary licenses of a new HIV-AIDS product

Today, Tibotec, a subsidiary of Johnson & Johnson, announced it has signed voluntary licensing agreements with several Indian and South African generic companies to allow generic competition on a new HIV-AIDS treatment, the investigational non-nucleoside reverse transcriptase inhibitor rilpivirine hydrochloride (TMC278) (rilpivirine hydrochloride), to certain developing countries. Continue Reading


WIPO SCCR21: Group B proposal on a work program for Copyright exceptions and limitations

Today, Wednesday November 10 2010, during the 3rd day of the WIPO SCCR21, the Group B presented a proposal for a Work Program on copyright exceptions and limitations for the WIPO SCCR. Group B is the negotiation group that groups developed countries like US, EU, Switzerland and others.

The proposal is available here

Continue Reading


Global Fund calls upon drug companies to “share without delay” AIDS drug patents with the Medicines Patent Pool

In a October 7, 2010 letter, Professor Michel Kazatchkine, the Executive Director of the Global Fund to fight AIDS, Tuberculosis and Malaria, has written to Dr. Jorge Bermudez, the UNITAID Executive Director, to discuss the Medicines Patent Pool.

Kazatchkine congratulates UNITAID for the announcement that an agreement had been reached between U.S. National Institute for Health and the Medicines Patent Pool for the voluntary license of the NIH patents rights on an HIV-AID drug, Darunavir.

Continue Reading


WIPO SCCR 20: Proyecto de conclusiones

Esta es la version de las 3.30 pm del 24 de junio del 2010 del proyecto de conclusiones de la OMPI SCCR 20 en espanol. El documento fue distribuido durante el dia de hoy por el secretariado de la OMPI y esta siendo discutido. Este texto va a ser negociado esta tarde.

Organización Mundial de la Propiedad Intelectual
Comité de Derecho de Autor y Derechos Conexos (SCCR)
Vigésima sesión
Ginebra, 21 a 24 de junio de 2010

Proyecto de conclusiones


Continue Reading

2008 U.S. Copyright Office Memo concluded that export of accessible works is not legal under U.S. law

In briefings about the WIPO proposal for a treaty for persons who are blind or have other disabilities, the U.S. government has sent mixed signals regarding the legality of exporting of accessible works created under exceptions in U.S. law. In some informal briefings and conversations, the U.S. government has said such exports are allowed under U.S. law. At other times, they say they are not.

KEI has obtained a June 12, 2008 memo from the U.S. Copyright Office, written by Neil Conley to David Carson, that analyzes the possible extraterritorial effects of the Chafee Amendment.

Continue Reading